Le Lézard
Classified in: Health
Subjects: PDT, TDS, PET, MAT

Pet Releaf Unveils Non-CBD Line of Wellness Products at 2024 Global Pet Expo


Attending Global Pet Expo for their 8th year, Pet Releaf is thrilled to announce an innovative line of supplements at the event.

DENVER, March 20, 2024 /PRNewswire/ -- Pet Releaf, the industry's first and leading plant-based pet CBD brand, is proud to share their new line of wellness products with attendees at the 2024 Global Pet Expo.

Pet Releaf's new products include a Postbiotic for dogs and cats of all ages, and a Fish-Free Omega 3.

Pet Releaf's line ? Pet Releaf Naturals ? is the first of the brand's non-hemp-based supplements. The two new wellness products are designed for all pet parents who want to take a proactive approach to their pets' health.

Every Pet Releaf Naturals product is:

The new products include a Postbiotic for dogs and cats of all ages, and a Fish-Free Omega 3. Both will be on display and available for pre-order at Global Pet Expo. Additional information for those not attending will be available soon at petreleaf.com.                      

"We're happy to continue helping pets with our high-quality products," Co-Founder Chelsea Gennings said. "We are thrilled to expand beyond our CBD-infused products to now offer non-hemp-based supplements with the same care, quality, and sustainability principles."

All of Pet Releaf's products continue to be science-backed, third-party tested, and formulated specifically for pets.

This is the 8th year Pet Releaf will attend Global Pet Expo, and each year the event has proven a valuable place to meet retailers and thought leaders in the industry.

As the leader in the pet CBD category, Pet Releaf continues to not only innovate new products but push forward CBD research and legislation. The brand will be available to answer questions about all products ? including their best-selling CBD oils, Edibites, and shampoos ? and provide continued education on what sets Pet Releaf apart.

Attendees can visit Pet Releaf at booth #226 throughout the duration of Global Pet Expo.

To learn more about Pet Releaf, visit petreleaf.com.

About Pet Releaf

Pet Releaf is the original plant-based pet CBD brand ? supporting pets, their parents, and the planet with sustainably made, veterinarian-formulated hemp-based solutions. Since its founding more than a decade ago, the company has led the industry with its commitment to education, transparency, and has transformed the lives of more than 5 million pets and their families. Sourced on regenerative farms in Colorado and awarded the NASC quality seal, Pet Releaf's products help reduce discomfort and irritation, support calm behavior and optimal digestion, and promote long-term health and general wellness. Learn more at petreleaf.com.

Media Contact
Miranda Carney
[email protected]

SOURCE Pet Releaf


These press releases may also interest you

at 09:52
Jumo Health?a global provider of age-appropriate, culturally relevant medical education?today announced that Kevin Aniskovich, the Company's President and CEO, will be moderating a roundtable discussion, "Why Authenticity and the Patient Voice is...

at 09:30
Canada Economic Development for Quebec Regions (CED) Supporting innovation and growth contributes to economic development in Quebec's regions. That is why Sophie Chatel, Member of Parliament for Pontiac, today announced, on behalf of the Honourable...

at 09:30
Adaptilens, Inc., a pre-clinical company dedicated to transforming the standard of care for cataract surgery, today announced the closing of a Series A financing round of $17.5 million led by Perceptive Xontogeny Venture Funds (PXV Funds), with...

at 09:20
Inflammasome Therapeutics (https://www.inflam.com), a private company developing a new class of inflammasome inhibitor drugs, Kamuvudines, as therapies for prevalent, degenerative diseases, announced the first patient has been dosed in a...

at 09:17
NanoAi Technologies, a company pioneering advancements in threat detection, today unveiled the NanoAi Technologies analyzer, a groundbreaking device designed to revolutionize security and safety measures across various sectors. This lightweight and...

at 09:15
The "Infectious Diseases Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access...



News published on and distributed by: